Inventor · disambiguated record
Michael Sendtner
Also filed as: SENDTNER MICHAEL · SENDTNER MICHAEL ANTON
1 granted patent·8 pending applications·1 citations·filing 1992–2023
15Inventor score
Files withHOFFMANN LA ROCHE3HOLTMANN BETTINA2REGENERON PHARMA1SENDTNER MICHAEL1UNIV WUERZBURG J MAXIMILIANS1
Top patents by PatentIndex Score
9 records- 0155US2025304958A1Method and molecules for reducing axonal tau protein accumulation through blocking of hnrnp r-mediated mapt mrna transport for treatment of alzheimer's diseaseUNIV WUERZBURG J MAXIMILIANS·Filed 2023·Application pending·0 cites
- 0253US2009253628A1Use of PEGylated IGF-I variants for the treatment of neuromuscular disordersHOLTMANN BETTINA·Filed 2009·Application pending·0 cites
- 0349US2014073567A1Use of pegylated igf-1 variants for the treatment of neuromuscular disordersHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0447US2017014488A1Use of pegylated igf-1 variants for the treatment of neuromuscular disordersHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 0543US2015273023A1Use of PEGylated IGF-I Variants For The Treatment Of Neuromuscular DisordersHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 0641US2011183903A1USE OF PEGylated IGF-I VARIANTS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERSHOLTMANN BETTINA·Filed 2011·Application pending·0 cites
- 0730US2004082014A1Method and test system for identifying substances which protect nerve cellsFiled 2002·Application pending·0 cites
- 0824US6602687B1DNA encoding human ciliary neurotrophic factor and method for producing the protein encoded therebyREGENERON PHARMA·Filed 1992·Granted Aug 5, 2003·1 cites·32 claims
- 0923US2008020964A1Test System for the Discovery of Substances for the Promotion of Neuraxonal GrowthSENDTNER MICHAEL·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Sendtner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →